These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17201666)

  • 1. Influence of aluminum-based adjuvant on the immune response to multiantigenic formulation.
    Iglesias E; Franch O; Carrazana Y; Lobaina Y; García D; Sanchez J; García J; Urquiza D; Muzio V; Guillén G; Aguilar JC
    Viral Immunol; 2006; 19(4):712-21. PubMed ID: 17201666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response.
    Kwissa M; Lindblad EB; Schirmbeck R; Reimann J
    J Mol Med (Berl); 2003 Aug; 81(8):502-10. PubMed ID: 12879151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the adjuvanticity of aluminum salts and their combination in hepatitis B recombinant protein vaccine in assessed mice.
    Mahboubi A; Fazeli MR; Dinarvand R; Samadi N; Sharifzadeh M; Ilka H; Azadi S; Soleimanian R; Kalkouei H; Hajikhanmirzaei R; Valadkhani M
    Iran J Immunol; 2008 Sep; 5(3):163-70. PubMed ID: 18791283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Humoral immune response of BALB/c mice immunized with chimer HBcAg proteins carrying the epitopes of surface hepatic B virus protein].
    Veremeĭko TA; Lebedev LR; Chikaev NA; Il'ichev AA; Karpenko LI
    Vopr Virusol; 2007; 52(1):40-5. PubMed ID: 17338233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HIV-1 and anti-HBV immune responses in mice after parenteral and nasal co-administration of a multiantigenic formulation.
    Iglesias E; García D; Carrazana Y; Aguilar JC; Sánchez A; Gorobaya L; Blanco A
    Curr HIV Res; 2008 Sep; 6(5):452-60. PubMed ID: 18855656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two mucosal-parenteral schedules to coadminister a multiantigenic formulation against HIV-1 in Balb/c mice.
    Iglesias E; García D; Márquez G; Prieto YC; Sánchez J; Trimiño L; Soria Y; García D
    Int Immunopharmacol; 2012 Mar; 12(3):487-93. PubMed ID: 22240123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th2-Th1 shift with the multiantigenic formulation TERAVAC-HIV-1 in Balb/c mice.
    García-Díaz D; Rodríguez I; Santisteban Y; Márquez G; Terrero Y; Brown E; Iglesias E
    Immunol Lett; 2013 Jan; 149(1-2):77-84. PubMed ID: 23183092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120.
    Jankovic D; Caspar P; Zweig M; Garcia-Moll M; Showalter SD; Vogel FR; Sher A
    J Immunol; 1997 Sep; 159(5):2409-17. PubMed ID: 9278332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars.
    Tonnis WF; Amorij JP; Vreeman MA; Frijlink HW; Kersten GF; Hinrichs WL
    Eur J Pharm Sci; 2014 May; 55():36-45. PubMed ID: 24468629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants.
    Sokolovska A; Hem SL; HogenEsch H
    Vaccine; 2007 Jun; 25(23):4575-85. PubMed ID: 17485153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
    Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G; Benjamin P; Soita H; Babiuk LA
    Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
    Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J
    J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant synergy in the response to hepatitis B vaccines.
    Wang S; Liu X; Caulfield MJ
    Vaccine; 2003 Oct; 21(27-30):4297-306. PubMed ID: 14505912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
    Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
    Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coinoculation with hepatitis B surface and core antigen promotes a Th1 immune response to a multiepitopic protein of HIV-1.
    Iglesias E; Thompson R; Carrazana Y; Lobaina Y; García D; Sánchez J; García J; Cruz O; Brown E; Martin A; Muzio VL; Aguilar JC
    Immunol Cell Biol; 2006 Apr; 84(2):174-83. PubMed ID: 16519735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.
    Hem SL; Hogenesch H
    Expert Rev Vaccines; 2007 Oct; 6(5):685-98. PubMed ID: 17931150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the effects of aluminum adjuvants and Freund's incomplete adjuvant on the immune response to an Edwardsiella tarda major antigen.
    Jiao XD; Cheng S; Hu YH; Sun L
    Vaccine; 2010 Feb; 28(7):1832-7. PubMed ID: 20006568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
    Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.